Anti-Influenza A H1N1 hemagglutinin antibody [10]
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal Hemagglutinin antibody. Carrier free. Suitable for WB and reacts with Influenza A virus (A/California/14/2009(H1N1)) samples. Cited in 1 publication.
View Alternative Names
Hemagglutinin, HA
- WB
Supplier Data
Western blot - Anti-Influenza A H1N1 hemagglutinin antibody [10] (AB281949)
Performed under reducing conditions.
All lanes:
Western blot - Anti-Influenza A H1N1 hemagglutinin antibody [10] (ab281949) at 1/1000 dilution
Lane 1:
Influenza A H1N1 (A/California/04/2009) Hemagglutinin / HA at 0.5 µg
Lane 2:
Influenza A H1N1 (A/California/04/2009) Hemagglutinin / HA at 0.1 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG H&L (Dylight800) at 1/10000 dilution
false
Reactivity data
Product details
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The H1N1 hemagglutinin plays a significant role in viral infectivity and spread. It exists as a homotrimer complex on the virus surface which undergoes conformational changes to mediate membrane fusion. This protein is also a major antigen that elicits immune responses leading to the production of H1N1 flu antibodies. Importantly the antigenic properties of hemagglutinin drive the need for seasonal flu vaccines as variations in its structure such as those seen in the H1N1 Brisbane strain can affect vaccine efficacy.
Pathways
H1N1 hemagglutinin functions within the viral entry and replication pathways. During infection it works alongside neuraminidase another surface protein to allow proper viral release from infected cells. The interaction between hemagglutinin and cellular sialic acids is important for initiating the viral replication cycle. These interactions mark the beginning of the RIG-I signaling pathway which triggers innate immune responses against the virus.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
mBio 16:e0073125 PubMed40626651
2025
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com